Guest

Dr. Fernando Camargo is a Principal Investigator at Boston Children’s Hospital and Professor in the Department of Stem Cell and Regenerative Biology at Harvard University. Dr. Camargo’s laboratory’s ultimate goal is to understand the signals that regulate adult stem cell maturation and tissue regeneration and has a strong interest in studying the cellular and molecular biology of hematopoietic stem cells.

CRISPR to Treat Muscle Disorder – Genome editing with CRISPR/Cas9 is a promising new approach for correcting or mitigating disease-causing mutations like that of Duchenne muscular dystrophy.

Development of a New Influenza Vaccine – Researchers present a systematic approach for vaccine development that eliminates interferon–modulating functions genome-wide while maintaining virus replication fitness.